Global Medical REIT (Global Medical REIT) GF Value : $11.97 (As of May. 09, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Global Medical REIT GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-09), Global Medical REIT's share price is $8.77. Global Medical REIT's GF Value is $11.97. Therefore, Global Medical REIT's Price-to-GF-Value for today is 0.73.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Global Medical REIT is Modestly Undervalued.

Global Medical REIT (NYSE:GMRE) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Global Medical REIT's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	8.77	/	11.97
	=	0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Medical REIT GF Value Related Terms

Thank you for viewing the detailed overview of Global Medical REIT's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Medical REIT (Global Medical REIT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Global Medical REIT Inc (NYSE:GMRE) » Definitions » GF Value

Comparable Companies

UHT DHC CHTH CHCT HLTC AHTR NHHS CVMCA STRW LTC WELL VTR PEAK OHI HR SBRA MPW DOC XBRU:AED NHI

Traded in Other Exchanges

GMREpA.PFD:USA 3UN:Germany 3UN:Germany

Address

7373 Wisconsin Avenue, Suite 800, Bethesda, MD, USA, 20814

Website

https://www.globalmedicalreit.com

Global Medical REIT Inc is a Maryland corporation engaged primarily in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to strong healthcare systems and physician groups. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases. Its tenants are physician groups, regional or national healthcare systems or combinations thereof. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation.

Executives

Moore Roscoe M Jr	director	C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244
Henry Cole	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Jeffrey Busch	director, officer: Chairman, President and CEO	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Lori Wittman	director	191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Matthew Cypher	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Paula Crowley	director	2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814
Ronald Marston	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Robert J Kiernan	officer: Chief Financial Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Alfonzo Leon	officer: Chief Investment Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Danica Holley	officer: Chief Operating Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Jamie Allen Barber	officer: Secretary and General Counsel	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Allen Webb	officer: SVP	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Huiqi Zhang	director, 10 percent owner	40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000
Notable Reward Ltd	10 percent owner	VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110
Superior Glory Enterprises Ltd.	10 percent owner	VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110